These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 6790233)

  • 1. Is penicillin alone effective in enterococcal endocarditis? An experimental study in rabbits.
    Thadepalli H; Mandal AK; Rambhatla K; Bach VT
    Chemotherapy; 1981; 27(5):340-9. PubMed ID: 6790233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy of experimental streptococcal endocarditis. II. Synergism between penicillin and streptomycin against penicillin-sensitive streptococci.
    Durack DT; Pelletier LL; Petersdorf RG
    J Clin Invest; 1974 Mar; 53(3):829-33. PubMed ID: 4492776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of gentamicin dose size on the efficacies of combinations of gentamicin and penicillin in experimental streptomycin-resistant enterococcal endocarditis.
    Wright AJ; Wilson WR; Matsumoto JY; Washington JA; Geraci JE
    Antimicrob Agents Chemother; 1982 Dec; 22(6):972-5. PubMed ID: 6818902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penicillin and netilmicin in treatment of experimental enterococcal endocarditis.
    Carrizosa J; Kaye D
    Antimicrob Agents Chemother; 1978 Mar; 13(3):505-8. PubMed ID: 122526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic synergism in enterococcal endocarditis.
    Carrizosa J; Kaye D
    J Lab Clin Med; 1976 Jul; 88(1):132-41. PubMed ID: 819602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of streptomycin-susceptible enterococcal experimental endocarditis with combinations of penicillin and low- or high-dose streptomycin.
    Henry NK; Wilson WR; Geraci JE
    Antimicrob Agents Chemother; 1986 Nov; 30(5):725-8. PubMed ID: 3800348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial therapy of experimental endocarditis caused by nutritionally variant viridans group streptococci.
    Henry NK; Wilson WR; Roberts RB; Acar JF; Geraci JE
    Antimicrob Agents Chemother; 1986 Sep; 30(3):465-7. PubMed ID: 3777910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daptomycin (LY146032) treatment of experimental enterococcal endocarditis.
    Bush LM; Boscia JA; Kaye D
    Antimicrob Agents Chemother; 1988 Jun; 32(6):877-81. PubMed ID: 2843085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penicillin prophylaxis of experimental S. viridans endocarditis.
    Durack DT; Petersdorf RG; Beeson PB
    Trans Assoc Am Physicians; 1972; 85():222-30. PubMed ID: 4660008
    [No Abstract]   [Full Text] [Related]  

  • 10. beta-Lactamase production in experimental endocarditis due to aminoglycoside-resistant Streptococcus faecalis.
    Ingerman M; Pitsakis PG; Rosenberg A; Hessen MT; Abrutyn E; Murray BE; Levison ME
    J Infect Dis; 1987 Jun; 155(6):1226-32. PubMed ID: 3106510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penicillin tolerance in experimental streptococcal endocarditis.
    Pulliam L; Inokuchi S; Hadley WK; Mills J
    Lancet; 1979 Nov; 2(8149):957. PubMed ID: 91047
    [No Abstract]   [Full Text] [Related]  

  • 12. Enterococcal endocarditis: duration and mode of treatment.
    Tompsett R; Berman W
    Trans Am Clin Climatol Assoc; 1978; 89():49-57. PubMed ID: 100924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo studies of streptomycin-resistant, penicillin-susceptible streptococci from patients with infective endocarditis.
    Enzler MJ; Rouse MS; Henry NK; Geraci JE; Wilson WR
    J Infect Dis; 1987 May; 155(5):954-8. PubMed ID: 3644854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of penicillin combined with an aminoglycoside against group B streptococci in vitro and in experimental endocarditis.
    Backes RJ; Rouse MS; Henry NK; Geraci JE; Wilson WR
    J Antimicrob Chemother; 1986 Oct; 18(4):491-8. PubMed ID: 3771432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal aminoglycoside dosing regimen for penicillin-tobramycin synergism in experimental Streptococcus adjacens endocarditis.
    Saleh-Mghir A; Cremieux AC; Vallois JM; Muffat-Joly M; Devine C; Carbon C
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2403-7. PubMed ID: 1489184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of the aminoglycoside dosing regimen in the penicillin-netilmicin combination for treatment of Enterococcus faecalis-induced experimental endocarditis.
    Fantin B; Carbon C
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2387-91. PubMed ID: 2128443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic concentrations in serum, serum bactericidal activity, and results of therapy of streptococcal endocarditis in rabbits.
    Carrizosa J; Kaye D
    Antimicrob Agents Chemother; 1977 Oct; 12(4):479-83. PubMed ID: 921242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of in-vitro penicillin tolerance in experimental enterococcal endocarditis.
    Kim KS; Bayer AS
    J Antimicrob Chemother; 1987 Apr; 19(4):475-85. PubMed ID: 3108228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHEMOTHERAPY OF BACTERIAL ENDOCARDITIS.
    DORMER AE
    Biochem Clin; 1963; 2():61-74. PubMed ID: 14095788
    [No Abstract]   [Full Text] [Related]  

  • 20. [Aminoglycosides in the treatment of infectious endocarditis].
    Malinverni R
    Schweiz Med Wochenschr Suppl; 1996; 76():14S-20S. PubMed ID: 8677414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.